Can Artificial Intelligence Accelerate Drug Approvals? RFK Jr.'s Bold Claim Sparks Debate
The integration of artificial intelligence (AI) into the U.S. Food and Drug Administration’s (FDA) drug approval process would allow new medications to be approved “very, very quickly,” according to a recent statement made by a prominent U.S. presidential candidate. The assertion, made at a high-profile live event, has ignited renewed debate about the potential of AI to revolutionize pharmaceutical regulation—raising questions of safety, ethics, and global implications, including for Thailand’s own drug approval landscape.